METTL3 and breast carcinoma: In breast cancer (BRC), by inhibiting let-7g to upregulate METTL3, HBXIP forms a positive feedback loop of HBXIP/let-7g/METTL3/HBXIP, leading to accelerated proliferation of breast cancer cells (15).